文献速递生殖医学

大型近亲婚配土耳其家系中HORMAD1双等位基因功能缺失变异与精子发生停滞相关

A biallelic loss of function variant in HORMAD1 within a large consanguineous Turkish family is associated with spermatogenic arrest.
PubMed 文献 · Hum Reprod · 2023-01-01

本研究对一个近亲婚配土耳其家系(父母为一级表亲,共7名子女,其中3名兄弟患非梗阻性无精子症)行全外显子组测序,发现3名患病兄弟均携带HORMAD1纯合无义变异c.1021C>T(p.Gln341*),父母及2名生育力正常兄弟为该变异携带者;体外实验显示突变蛋白截短并滞留于细胞质,提示HORMAD1为人类减数分裂过程的重要遗传因子。

要点

  • 3名患非梗阻性无精子症的兄弟均携带HORMAD1纯合无义变异c.1021C>T(p.Gln341*)。
  • 父母及2名生育力正常兄弟为该变异携带者,符合常染色体隐性遗传模式。
  • 突变蛋白截短且定位于细胞质,野生型蛋白定位于细胞核。

核心结论

  • 本研究发现HORMAD1纯合无义变异与土耳其家系中3名兄弟的非梗阻性无精子症相关,验证HORMAD1为人类减数分裂过程中的重要遗传因子。
  • 作者认为该报告应促使其他研究者对非梗阻性无精子症患者筛查该遗传变异。
  • 作者指出HORMAD1也可能参与人类女性不孕,因Hormad1-/-敲除雌鼠同样不孕。

研究设计与样本

  • 研究纳入一个近亲婚配土耳其家系,父母为一级表亲,共7名子女:3名儿子患非梗阻性无精子症、2名儿子生育力正常、2名女儿信息不可得。
  • 采集先证者、其2名患病兄弟、父母及2名未患病兄弟共7份唾液样本。
  • 全外显子组测序前,先证者接受包含133个不孕相关基因的靶向遗传检测,未发现致病性变异。
  • 对7名可及家系成员DNA行全外显子组测序,用内部流程进行生物信息学分析,并对检出的变异进行评分排序及拷贝数变异检测与注释。
  • 通过细胞转染后进行免疫荧光或免疫印迹,研究突变对蛋白表达与定位的影响。

主要发现

  • 全外显子组测序发现HORMAD1(NM_032132.5)第13外显子纯合无义变异chr1:150675797G>A;c.1021C>T,p.Gln341*,在3名患病兄弟中均得到确认。
  • 父母及2名生育力正常兄弟为该变异携带者。
  • 该变异可能产生缺乏核定位信号的截短蛋白。
  • 免疫印迹实验证实产生截短的HORMAD1蛋白,免疫荧光显微镜显示突变蛋白呈细胞质定位,而野生型蛋白定位于细胞核。

关键数值与推荐

  • 按一种用于评估男性不孕基因临床有效性的评分系统,本研究将HORMAD1归类为在男性不孕中涉及的临床证据有限。
  • 作者指出,仅分析一个家系时该评分为最高可能得分,若增加一名携带致病或可能致病变异的患者,该分类将立即变为「中等」。

临床怎么用

  • 作者认为本发现对患者及其家庭成员的遗传咨询有直接意义。
  • 作者认为识别参与人类减数分裂过程的新遗传因子将改善基础知识,进而有助于为不孕患者提供更好的照护。
  • 作者建议其他研究者对非梗阻性无精子症患者筛查该遗传变异。

局限性

  • 按一种用于评估男性不孕基因临床有效性的评分系统,本研究将HORMAD1归类为在男性不孕中涉及的临床证据有限。
  • 作者指出,仅分析一个家系时该评分为最高可能得分,若增加一名携带致病或可能致病变异的患者,该分类将立即变为「中等」。
  • 作者认为本报告应促使其他研究者对非梗阻性无精子症患者筛查该遗传变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can the analysis of a large Turkish consanguineous family via whole exome sequencing (WES) identify novel causative genetic variation responsible for nonobstructive azoospermia (NOA) characterized by arrest at primary spermatocyte stage? SUMMARY ANSWER: WES analysis revealed a homozygous nonsense variant in HORMAD1 in three affected brothers of a Turkish family. WHAT IS KNOWN ALREADY: Studying patient cohorts in small or large consanguineous families using high-throughput sequencing allows the identification of genetic causes of different pathologies, including infertility. Over the last two decades, a number of genes involved in human male infertility have been discovered, but only 14 genes have been identified as being at least moderately linked to isolated NOA or oligozoospermia in men. STUDY DESIGN, SIZE, DURATION: The study included a Turkish family comprising three brothers with NOA. Two brothers had a normal karyotype, normal hormonal levels and no Yq microdeletion. The testicular histopathology analysis revealed the complete arrest of spermatogenesis at the primary spermatocyte stage. PARTICIPANTS/MATERIALS, SETTING, METHODS: We recruited a consanguineous Turkish family where parents were first-degree cousins and had seven children; three sons who had NOA, two sons who were fertile and two daughters for whom no information was available. Saliva samples from the index patient, his two affected brothers, parents and two nonaffected brothers (seven samples in total) were collected. Prior to WES, the index patient underwent targeted genetic testing using an infertility panel, which includes 133 infertility genes. No pathogenic variations were identified. WES was then performed on the DNA of the seven family members available. Bioinformatics analysis was performed using an in-house pipeline. Detected variants were scored and ranked, and copy number variants were called and annotated.The consequences of mutation on protein expression and localization were investigated by cell transfection followed by immunofluorescence or immunoblotting. MAIN RESULTS AND THE ROLE OF CHANCE: WES revealed a homozygous nonsense variant chr1:150675797G>A; HORMAD1 (NM_032132.5): c.1021C>T, p.Gln341* in exon 13, which was confirmed in all three affected brothers. HORMAD1 encodes the HORMA domain-containing protein 1. The parents as well as the two fertile brothers were carriers of this variant. This variant may lead to the production of a truncated protein lacking the nuclear localization signal; therefore, human cells were transfected with the wild-type and mutated form, in fusion with green fluorescent protein. Immunoblotting experiments confirmed the production of a truncated HORMAD1 protein, and immunofluorescence microscopy revealed that the mutated protein displayed cytoplasmic localization while the wild type protein located to the nucleus. Altogether, our findings validate HORMAD1 as an essential genetic factor in the meiotic process in human. LIMITATIONS, REASONS FOR CAUTION: According to one scoring system used to evaluate the clinical validity of male infertility genes, this study would classify HORMAD1 as displaying limited clinical evidence of being involved in male infertility. However, such a score is the maximum possible when only one family is analyzed and the addition of one patient showing a pathogenic or likely pathogenic variant would immediately change this classification to 'moderate'. Thus, this report should prompt other researchers to screen patients with NOA for this genetic variant. WIDER IMPLICATIONS OF THE FINDINGS: Identification of new genetic factors involved in the human meiosis process will contribute to an improvement of our knowledge at the basic level, which in turn will allow the management of better care for infertile patients. Since Hormad1-/- knock-out female mice are also infertile, HORMAD1 could also be involved in human female infertility. Our findings have direct implications for the genetic counseling of patients and their family members. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by Fondation Maladies Rares (High Throughput Sequencing and Rare Diseases-2018, 'GenOmics of rare diseases'). The authors declare that they have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Okutman O, Boivin M, Muller J, et al. A biallelic loss of function variant in HORMAD1 within a large consanguineous Turkish family is associated with spermatogenic arrest. Hum Reprod. 2023. PMID: 36524333. doi:10.1093/humrep/deac259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。